Difference between revisions of "Eckmann 2014 Mol Neurobiol"
Bader Helga (talk | contribs) |
Beno Marija (talk | contribs) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP (2014) Mitochondrial | |title=Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP (2014) Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime. Mol Neurobiol 50:107-18. | ||
|info=[http://www.ncbi.nlm.nih.gov/pubmed/24633813 PMID: 24633813] | |info=[http://www.ncbi.nlm.nih.gov/pubmed/24633813 PMID: 24633813] | ||
|authors=Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP | |authors=Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP | ||
|year=2014 | |year=2014 | ||
|journal=Mol Neurobiol | |journal=Mol Neurobiol | ||
|abstract=Huntington disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of the huntingtin gene (HTT). One prominent target of the mutant huntingtin protein (mhtt) is the mitochondrion, affecting its morphology, distribution, and function. Thus, mitochondria have been suggested as potential therapeutic targets for the treatment of HD. Olesoxime, a cholesterol-like compound, promotes motor neuron survival and neurite outgrowth in vitro, and its effects are presumed to occur via a direct interaction with mitochondrial membranes ( | |abstract=Huntington disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of the huntingtin gene (HTT). One prominent target of the mutant huntingtin protein (mhtt) is the mitochondrion, affecting its morphology, distribution, and function. Thus, mitochondria have been suggested as potential therapeutic targets for the treatment of HD. Olesoxime, a cholesterol-like compound, promotes motor neuron survival and neurite outgrowth ''in vitro'', and its effects are presumed to occur via a direct interaction with mitochondrial membranes (mtMs). We examined the properties of mtMs isolated from cell and animal models of HD as well as the effects of olesoxime on mtM fluidity and cholesterol levels. mtMs isolated from brains of aged Hdh Q111/Q111 knock-in mice showed a significant decrease in 1,6-diphenyl-hexatriene (DPH) anisotropy, which is inversely correlated with membrane fluidity. Similar increases in mtM fluidity were observed in striatal STHdh Q111/Q111 cells as well as in mtMs isolated from brains of BACHD transgenic rats. Treatment of STHdh cells with olesoxime decreased the fluidity of isolated mtMs. Decreased membrane fluidity was also measured in olesoxime-treated mtMs isolated from brains of HD knock-in mice. In both models, treatment with olesoxime restored HD-specific changes in mtMs. Accordingly, olesoxime significantly counteracted the mhtt-induced increase in mtM fluidity of mtMs isolated from brains of BACHD rats after 12 months of treatment ''in vivo'', possibly by enhancing mtM cholesterol levels. Thus, olesoxime may represent a novel pharmacological tool to treat mitochondrial dysfunction in HD. | ||
|keywords=BACHDrat , Huntington disease, Membrane cholesterol, Membrane fluidity, Mitochondrial membrane | |keywords=BACHDrat , Huntington disease, Membrane cholesterol, Membrane fluidity, Mitochondrial membrane | ||
|mipnetlab=DE | |mipnetlab=DE Giessen Eckert GP | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area=mt-Membrane, Genetic knockout;overexpression | |||
|organism=Mouse, Rat | |||
|diseases=Neurodegenerative | |diseases=Neurodegenerative | ||
|instruments=Oxygraph-2k | |||
}} | }} | ||
Latest revision as of 10:49, 27 March 2018
| Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP (2014) Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime. Mol Neurobiol 50:107-18. |
Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP (2014) Mol Neurobiol
Abstract: Huntington disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of the huntingtin gene (HTT). One prominent target of the mutant huntingtin protein (mhtt) is the mitochondrion, affecting its morphology, distribution, and function. Thus, mitochondria have been suggested as potential therapeutic targets for the treatment of HD. Olesoxime, a cholesterol-like compound, promotes motor neuron survival and neurite outgrowth in vitro, and its effects are presumed to occur via a direct interaction with mitochondrial membranes (mtMs). We examined the properties of mtMs isolated from cell and animal models of HD as well as the effects of olesoxime on mtM fluidity and cholesterol levels. mtMs isolated from brains of aged Hdh Q111/Q111 knock-in mice showed a significant decrease in 1,6-diphenyl-hexatriene (DPH) anisotropy, which is inversely correlated with membrane fluidity. Similar increases in mtM fluidity were observed in striatal STHdh Q111/Q111 cells as well as in mtMs isolated from brains of BACHD transgenic rats. Treatment of STHdh cells with olesoxime decreased the fluidity of isolated mtMs. Decreased membrane fluidity was also measured in olesoxime-treated mtMs isolated from brains of HD knock-in mice. In both models, treatment with olesoxime restored HD-specific changes in mtMs. Accordingly, olesoxime significantly counteracted the mhtt-induced increase in mtM fluidity of mtMs isolated from brains of BACHD rats after 12 months of treatment in vivo, possibly by enhancing mtM cholesterol levels. Thus, olesoxime may represent a novel pharmacological tool to treat mitochondrial dysfunction in HD. • Keywords: BACHDrat, Huntington disease, Membrane cholesterol, Membrane fluidity, Mitochondrial membrane
• O2k-Network Lab: DE Giessen Eckert GP
Labels: MiParea: mt-Membrane, Genetic knockout;overexpression
Pathology: Neurodegenerative
Organism: Mouse, Rat
HRR: Oxygraph-2k
